Levi & Korsinsky Reminds Cardlytics Investors of Class Action Lawsuit
Levi & Korsinsky, LLP is officially notifying investors about the ongoing class action lawsuit involving Cardlytics, Inc., whose securities are traded on NASDAQ under the ticker symbol CDLX. This legal action arises from allegations of securities fraud affecting shareholders within a specified time frame.
Overview of the Class Action Lawsuit
The lawsuit focuses on losses incurred by investors in Cardlytics due to alleged fraudulent activity during the period from March 14, 2024, to August 7, 2024. The plaintiffs believe that the company's positive statements regarding its business performance were misleading and not reflective of its actual financial situation.
The allegations assert that several statements made by the defendants concealed critical information. For instance:
1. Increased consumer engagement supposedly led to heightened consumer incentives in an exaggerated manner.
2. Cardlytics was unable to adequately increase its billings to correspond with the reported consumer engagement gains.
3. There was a significant risk that revenue growth could slow or decline as a result.
4. Mismanagement in the Ads Decision Engine resulted in the 'under-delivery' of budgets and billing estimates.
5. Consequently, the defendants’ previous positive claims about the company's operations were rendered materially false and misleading.
Important Dates and Requirements
Investors affected by these alleged fraudulent statements have until March 25, 2025, to request consideration for appointment as lead plaintiff in this class action suit. It's crucial for investors to know that participating in this lawsuit doesn't require one to act as the lead plaintiff for them to potentially receive a share of any compensation awarded. This lawsuit aims to hold those responsible accountable while providing recovery for the affected parties based on their respective losses.
No Financial Cost to Participants
One of the critical appeals of getting involved with the Levi & Korsinsky class action is that it offers an opportunity for affected shareholders to seek compensation without the burden of upfront legal fees. If you are a member of the affected group, you're encouraged to explore your options as there are no costs required to participate.
Legacy of Levi & Korsinsky
Levi & Korsinsky has established a solid reputation over the past two decades, recovering vast amounts for shareholders affected by corporate malfeasance. The law firm has proven success in navigating high-stakes securities litigation, boasting a talented team of over 70 specialists dedicated to serving investor needs. For seven consecutive years, it ranked among the top 50 securities litigation firms in the United States as reported by ISS Securities Class Action Services.
Contact Information
For additional guidance or queries about the lawsuit, investors can reach out directly to:
- - Joseph E. Levi, Esq.
- - Email: [email protected]
- - Phone: (212) 363-7500
The firm is located at 33 Whitehall Street, 17th Floor, New York, NY 10004. Visit their website for further updates and information relevant to this class action:
www.zlk.com.
In conclusion, this upcoming deadline for leading plaintiffs in the Cardlytics class action is crucial for any impacted investors. Contact Levi & Korsinsky to discuss the grounds on which you may join this potentially rewarding legal pursuit.